Page last updated: 2024-12-05

n,n-bis(2-hydroxyethyl)glycine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

n,n-bis(2-hydroxyethyl)glycine, also known as bicine, is a zwitterionic buffer commonly used in biological and biochemical research. It is synthesized by reacting glycine with ethylene oxide. Bicine is a good buffer in the pH range of 7.4 to 8.2 and is often used in protein crystallization, enzymatic reactions, and cell culture. Its importance lies in its ability to maintain a stable pH environment, which is crucial for many biological processes. It is studied because of its effectiveness as a buffer and its compatibility with various biological systems. Bicine is non-toxic and readily soluble in water, making it a versatile tool for researchers.'

N,N-bis(2-hydroxyethyl)glycine: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

N,N-bis(2-hydroxyethyl)glycine : A bicine that is a Good's buffer substance, pKa = 8.35 at 20 degreeC. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID8761
CHEBI ID40957
SCHEMBL ID34161
MeSH IDM0089318

Synonyms (80)

Synonym
n,n-bis(.beta.-hydroxyethyl)glycine
bicine ,
n,n-bis(2-hydroxyethyl)aminoacetic acid
bicene
n,n-bis(hydroxyethyl)glycine
n,n-bis(2-hydroxyethyl)glycine
150-25-4
n,n-dihydroxyethylglycine
nsc7512
n,n-dihydroxyethyl glycine
dihydroxyethylglycine
n,n-(2-hydroxyethyl)glycine
diethanol glycine
n,n-di(2-hydroxyethyl)glycine
fe-3-specific
nsc-7342
glycine,n-dihydroxyethyl-
glycine,n-bis(2-hydroxyethyl)-
bis(2-hydroxyethyl)glycine
wln: qv1n2q2q
nsc7342
diethylolglycine
dheg
nsc-7512
einecs 205-755-1
glycine, n,n-bis(2-hydroxyethyl)-
n,n-bis(beta-hydroxyethyl)glycine
n,n-(2-dihydroxyethyl)glycine
nsc 7342
brn 1769362
glycine, n,n-dihydroxyethyl-
2-[bis(2-hydroxyethyl)amino]acetic acid
bicine, >=99% (titration)
bicine, bioxtra, >=99% (titration)
CHEBI:40957
DB03709
bicine, bioultra, >=99.5% (t)
diethanolglycine
B0484
STK802165
2-(bis(2-hydroxyethyl)amino)acetic acid
A809025
AKOS005622671
4-04-00-02390 (beilstein handbook reference)
1j484qfi1o ,
unii-1j484qfi1o
BBL011024
FT-0622946
di(hydroxyethyl)glycine
bicine [mi]
2-hxg
n,n-bis(hydroxyethyl)aminoacetic acid
n,n-di(hydroxyethyl)aminoacetic acid
S6276
AB00443773-03
SCHEMBL34161
n,n-bis-(2-hydroxyethyl)aminoacetic acid
di(hydroxyethyl)aminoacetic acid
n,n-bis-(2-hydroxyethyl) aminoacetic acid
n,n-di(hydroxyethyl)glycine
W-201338
[bis(2-hydroxyethyl)amino]acetic acid #
HMS3604E14
DTXSID3041669
mfcd00004295
n,n-bis(2-hydroxyethyl)glycine]
n,n-bis(2-hydroxyethyl)-glycine
SY010805
Q4903636
chelest ga; dheg;nsc 7342; nsc 7512;diethanol glycine
AS-12494
bicine high purity grade 100g
AC8058
NCGC00342441-01
EN300-7244555
CS-0015178
HY-D0868
bicine (cell culture suitable)
n,n-bis-(2-hydroxyethyl)-glycine
Z336127920

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" 7 These data show that five of the most commonly used artificial buffers, to study muscles in vitro, exert adverse effects on contractility of arterial and venous smooth muscle."( Adverse effects of artificial buffers on contractile responses of arterial and venous smooth muscle.
Altura, BM; Altura, BT; Carella, A; Turlapaty, PD, 1980
)
0.26
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
bicineA Good's buffer substance that is N,N-bis(2-hydroxyethyl)glycine or its zwitterionic/carboxylate form.
bicineA Good's buffer substance that is N,N-bis(2-hydroxyethyl)glycine or its zwitterionic/carboxylate form.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (26)

TimeframeStudies, This Drug (%)All Drugs %
pre-199011 (42.31)18.7374
1990's4 (15.38)18.2507
2000's4 (15.38)29.6817
2010's6 (23.08)24.3611
2020's1 (3.85)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.21

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.21 (24.57)
Research Supply Index3.30 (2.92)
Research Growth Index4.51 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.21)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (3.85%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other25 (96.15%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]